
About AtaCor Medical
AtaCor Medical is a Healthcare company based in San Clemente (United States) founded in 2014 by Alan Marcovecchio, Rick Sanghera, and Sean McGeehan. An implantable pacemaker system is developed for cardiac pacing therapy. AtaCor Medical has raised $136.8 million across 4 funding rounds from investors including Longview Partners, Broadview Ventures and aMoon. The company has 15 employees. Its chief executive, as recorded, is Rick Sanghera. AtaCor Medical offers products and services including EV Temporary Pacing Lead System and EV-ICD Lead System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is ATACOR MEDICAL, INC. Its competitors include AtriCure, CardioFocus and Kestra Medical Technologies; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.
- Headquarters San Clemente, United States
- Employees 15
- Founders Alan Marcovecchio, Rick Sanghera, Sean McGeehan
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website atacor.com
- Social LinkedIn X
- Legal Name Atacor Medical, Inc.
- Total Equity Funding$136.8M (USD)
in 4 rounds
- Latest Funding Round$75M (USD), Series D
Oct 2025
- InvestorsLongview Partners
& 6 more
- Employee Count15
Products & Services of AtaCor Medical
AtaCor Medical offers a comprehensive portfolio of products and services, including EV Temporary Pacing Lead System and EV-ICD Lead System.
Provides temporary pacing without entering the heart or vascular system.
Delivers defibrillation and ATP without transvenous leads for safety.
Funding Insights of AtaCor Medical
AtaCor Medical has successfully raised a total of $136.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $136.8M
- Total Rounds 4
- Last Round Series D β $75M
- First Round $8.8M
(Sep 2018)
- Investors Count 7
All 4 funding rounds of AtaCor Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $75M | Series D | β | β | β |
| Apr 2024 | $28M | Series C | β | Arboretum Ventures | |
| Apr 2020 | $25M | Series B | β | Longview Partners, Hatteras Venture Partners | |
| Sep 2018 | $8.8M | Series A | β | Broadview Ventures, aMoon | β |
7 investors in total: 7 institutional.
Investors in AtaCor Medical
AtaCor Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Longview Partners, Broadview Ventures and aMoon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage life sciences investments are made in the US. | broadviewventures.org | Boston, United States | ||
Venture capital investments in healthcare are focused on by aMoon. | amoon.fund | |||
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe | hatterasvp.com | Durham, United States | ||
| chv.vc | ||||
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
BayMed Venture Partners is focused on investing in early-stage medical device and digital health companies. | baymedvp.com | San Francisco, United States | ||
Investment management services are provided by Longview Partners in London. | 2001 | longview-partners.com | London, United Kingdom |
Investor details for AtaCor Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AtaCor Medical
22 people are tracked at AtaCor Medical (9 in leadership, 8 in board & advisors, 5 in team); the tracked headcount is 15.
| Name | Role | Group |
|---|---|---|
Alan Marcovecchio | Co-Founder & President | Leadership |
Rick Sanghera | Co-Founder & CEO | Leadership |
Sean McGeehan | Co-Founder & CFO | Leadership |
Martin Burke | Chief Medical Officer | Leadership |
Don Scheck | Director Field Clinical Engineers | Leadership |
Libet Garber, Ph.D. | Director of Regulatory Affairs | Leadership |
Jan Bregman | Director, Quality Systems | Leadership |
Matthew Rollins | Vice President Of Product Development | Leadership |
Sarah Hase, BS, CCRA | Director, Clinical Operations | Leadership |
Jeff Terrell | Director | Board & advisors |
Darshana Zaveri | Director | Board & advisors |
Maria Berkman | Chairperson Of The Board | Board & advisors |
Uri Yaron | Director | Board & advisors |
Gary Gershony | Scientific Advisor | Board & advisors |
Vivek Reddy | Scientific Advisor | Board & advisors |
Reinoud Knops | Scientific Advisor | Board & advisors |
Steven Girouard | Director | Board & advisors |
TJ Ho | Quality Engineer | Team |
Sterling Erickson | Principal Research And Development Engineer | Team |
Rahul Veetekat | Principal R&d Engineer | Team |
2 more people are available in the full profile.
Complete people profiles for AtaCor Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of AtaCor Medical
3 dated milestones of AtaCor Medical across 11 years, from founding to its latest funding, stage changes and deals.
- Founded AtaCor Medical is founded.
- Funding First funding round of $8.8M.
- Funding Latest funding round, Series D, of $75.0M.
Competitors of AtaCor Medical
AtaCor Medical has 3 listed competitors in our database, 2 of them funded. They include AtriCure, CardioFocus and Kestra Medical Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| atricure.com | 2000 | Mason, United States | 1,874 | Cardiac ablation and occlusion devices for atrial fibrillation are provided. | ||
| cardiofocus.com | 1990 | Marlborough, United States | $260.86M | 105 | Endoscopic catheter for atrial fibrillation ablation is developed. | |
| kestramedical.com | 2014 | Kirkland, United States | $196M | 118 | Medical devices are developed to support cardiovascular patients at risk. |
Detailed competitors of AtaCor Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as AtaCor Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Atacor Medical
Complete news archive for AtaCor Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AtaCor Medical
AtaCor Medical was founded in 2014 and raised its 1st funding round 4 years after it was founded.
AtaCor Medical is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Rick Sanghera is the CEO of AtaCor Medical, as recorded in our data. They have also founded this company.
AtaCor Medical is a funded company, having raised a total of $136.8M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.8M, raised on Sep 2018.
AtaCor Medical has 15 employees.
Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.
AtaCor Medical's top competitors include AtriCure, CardioFocus and Kestra Medical Technologies.
AtaCor Medical offers EV Temporary Pacing Lead System and EV-ICD Lead System.
AtaCor Medical has 7 investors. Key investors include Longview Partners, Broadview Ventures, aMoon, Hatteras Venture Partners, and CHV.
AtaCor Medical operates through Atacor Medical, Inc..
